NCT02096718View on ClinicalTrials.gov

Afatinib in Subjects With Kidney Dysfunction

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Renal Insufficiency
Interventions
DRUG

Afatinib healthy

DRUG

Afatinib severe renally impaired

DRUG

Afatinib moderate renally impaired

Trial Locations (1)

Unknown

1200.216.1 Boehringer Ingelheim Investigational Site, Kiel

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY